South Cone investments sells Rani Therapeutics (RANI) shares for $15.7m
PositiveFinancial Markets

South Cone Investments has successfully sold its shares in Rani Therapeutics for $15.7 million, marking a significant financial move. This sale not only reflects the growing confidence in Rani's innovative drug delivery technology but also highlights South Cone's strategic investment decisions. Such transactions are crucial as they can influence market trends and investor sentiment, showcasing the potential for future growth in the biotech sector.
— Curated by the World Pulse Now AI Editorial System